Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arteris (AIP) Change in Accured Expenses (2023 - 2025)

Historic Change in Accured Expenses for Arteris (AIP) over the last 3 years, with Q3 2025 value amounting to $1.9 million.

  • Arteris' Change in Accured Expenses rose 3968.37% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 3450.56%. This contributed to the annual value of $3.1 million for FY2024, which is 2480.75% up from last year.
  • Latest data reveals that Arteris reported Change in Accured Expenses of $1.9 million as of Q3 2025, which was up 3968.37% from $1.7 million recorded in Q2 2025.
  • Arteris' 5-year Change in Accured Expenses high stood at $1.9 million for Q3 2025, and its period low was -$2.0 million during Q1 2025.
  • Its 3-year average for Change in Accured Expenses is $655636.4, with a median of $990000.0 in 2023.
  • The largest annual percentage gain for Arteris' Change in Accured Expenses in the last 5 years was 31223.47% (2025), contrasted with its biggest fall of 31869.47% (2025).
  • Arteris' Change in Accured Expenses (Quarter) stood at $923000.0 in 2023, then soared by 71.72% to $1.6 million in 2024, then rose by 22.59% to $1.9 million in 2025.
  • Its Change in Accured Expenses stands at $1.9 million for Q3 2025, versus $1.7 million for Q2 2025 and -$2.0 million for Q1 2025.